Noumed Pharmaceuticals – a major global supplier of prescription and over-the-counter medicines and therapeutics – will establish an $85 million manufacturing facility at Salisbury South, SA, thanks to a $20 million funding package from the Federal Government.
Noumed currently manufactures all of the products it supplies to the Australian market offshore, but will become almost entirely self-sufficient when the new facility opens by 2025.
Federal Finance Minister and Senator for South Australia Simon Birmingham said the project was expected to create up to 250 jobs during the construction phase and a further 180 ongoing positions.
“South Australia has a proven track-record of attracting global companies and it’s no coincidence that a global pharmaceutical company like Noumed has chosen South Australia for the site of its first Australian manufacturing facility,” Minister Birmingham continued.
“The pandemic has shown us how easily global supply chains can be interrupted, which is why we’re backing manufacturing projects that will boost our sovereign capability to produce critical products such as pharmaceuticals.”
South Australian Premier Steven Marshall thanked the Commonwealth and Noumed for investing in the state.
“Noumed’s presence in South Australia will do more than just create good local manufacturing jobs,” Premier Marshall said.
“The company will also have a strong focus on research and development, creating job opportunities across the workforce for scientists, pharmacy graduates, logistics experts and engineers, as well as opportunities for collaboration with our local research institutions.
“These are exactly the sorts of projects we have been working hard to deliver for our State, bringing with them the jobs of the future and the economic growth that benefits us all.”
